Financial Performance - For Q3 2024, the company's operating revenue was RMB 1,231,523,140.11, a decrease of 8.80% compared to the same period last year[4] - The net profit attributable to shareholders was RMB 116,430,360.57, representing a significant increase of 487.43% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 99,358,854.26, up 1,631.43% from the previous year[4] - The company reported a basic earnings per share of RMB 0.0794, an increase of 488.15% compared to the same period last year[4] - Net profit rose by 449.08% to ¥779,059,287.68, reflecting the overall improvement in operating profit[10] - Basic and diluted earnings per share for the current period were both RMB 0.5317, compared to RMB 0.0976 in the previous period, marking an increase of approximately 444.43%[23] - The total comprehensive income for the current period was RMB 713,437,124.04, compared to RMB 242,978,158.09 in the previous period, indicating a growth of approximately 194.00%[23] Cash Flow - The cash flow from operating activities for the year-to-date was RMB 1,792,139,231.56, an increase of 865.91% compared to the same period last year[4] - Cash flow from operating activities improved significantly, with a net increase of 865.91% to ¥1,792,139,231.56, driven by higher cash receipts from sales[11] - Operating cash flow for the current period is RMB 1,792,139,231.56, compared to a negative cash flow of RMB -233,988,970.92 in the previous period, indicating a significant recovery[25] - Cash received from sales of goods and services decreased to RMB 4,299,443,691.71 from RMB 4,603,550,675.54, a decline of approximately 6.6%[25] - Cash paid for purchasing goods and services significantly decreased to RMB 1,477,390,948.62 from RMB 3,633,091,884.41, a reduction of about 59.3%[25] - Cash inflow from investment activities decreased to RMB 1,515,558,196.54 from RMB 2,301,332,024.93, reflecting a decline of approximately 34%[26] - Net cash flow from financing activities shows a significant outflow of RMB -1,345,954,669.90, worsening from RMB -672,098,505.03 in the previous period[26] - The total cash and cash equivalents at the end of the period increased to RMB 1,995,479,199.24, up from RMB 1,757,779,083.22 in the previous period[27] Assets and Liabilities - The total assets at the end of the reporting period were RMB 18,121,417,326.69, a decrease of 5.63% from the end of the previous year[4] - Total non-current assets decreased to RMB 7,749,434,630.32, down 9.93% from RMB 8,599,510,606.98 at the beginning of the period[18] - Total liabilities decreased to RMB 5,906,888,588.09, down 18.11% from RMB 7,215,037,414.42 at the beginning of the period[20] - The total equity attributable to shareholders increased to RMB 12,140,384,965.66, reflecting a growth of 1.91% year-on-year[4] - The total equity attributable to shareholders increased to RMB 12,140,384,965.66, up 1.91% from RMB 11,913,149,195.32 at the beginning of the period[20] Investments - The company experienced a 102.03% increase in trading financial assets, totaling RMB 836,795,932.21, primarily due to increased investments in financial products[8] - Long-term equity investments decreased by 50.58% to RMB 496,236,843.73, mainly due to the disposal of shares in HighTide Therapeutics, Inc.[8] - Investment income increased by 251.52% to ¥416,440,156.93, primarily from the disposal of equity and fund investments[9] - The company reported an investment income of RMB 416,440,156.93, a turnaround from a loss of RMB 274,834,971.73 in the previous period[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 27,499, with the top ten shareholders holding significant stakes[12] - Shenzhen Lerun Technology Co., Ltd. held 32.31% of shares, while Xiamen Jintian Tuti Investment Partnership held 27.81%[12] - The company has a strong shareholder base, with the top three shareholders collectively owning over 75% of the shares[12] Expenses - Sales expenses decreased by 30.26% to ¥280,983,594.46 due to reduced marketing costs[9] - Research and development expenses decreased to RMB 129,976,981.05 from RMB 152,223,825.20, a reduction of about 14.58%[21] - The company’s tax expenses increased to RMB 108,143,486.10 from RMB 39,289,379.06, reflecting an increase of approximately 175.00%[22] Other Information - The company reported a significant increase in non-operating income due to government subsidies amounting to RMB 5,108,928.12 for Q3 2024[5] - The company experienced a foreign exchange loss of RMB 60,898,382.20, contrasting with a gain of RMB 103,834,456.09 in the previous period[23] - The impact of exchange rate changes on cash and cash equivalents was a positive RMB 9,871,785.63, compared to RMB 31,821,093.12 in the previous period[27] - The company did not undergo an audit for the third quarter report[28]
海普瑞(09989) - 2024 Q3 - 季度业绩